Diligence memo · auto-generated · as of July 2, 2026
Pathology Watch Inc.
Pathology Watch Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Pathology Watch Inc. operates in Other Technology, based in MURRAY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Pathology Watch Inc. has raised $29M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $22M on 2021-12-29.
Most recent recorded round closed around 2021-12-29.
Valuation (modeled)modeled
Provath models Pathology Watch Inc. at approximately $403M (range $55M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.80× the median modeled value of Series B Other Technology companies in 2019–2021 (415 peers) — value vs value, same stage and era. Within the normal band (80% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 4.5 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 5.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 88% of Other Technology peers (21302 compared).
Modeled value ranks above 91% of those peers.
Closest niche peers: Visual Lease, LLC, Decisions, LLC, Suvoda LLC, SmartRecruiters, Inc., Litify Inc..
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.